학술논문

CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S285-S286
Subject
Language
ISSN
2152-2650